Since Thal is a "consultant" for a biotech outfit maybe he can fill us in on what it is specifically CYGX is lacking for pre clinicals. Others without Thals expertise have tried. So Thal just what could those reasons be? Others have expressed themselves discussing this very venue so please do. I would so love to hear from a biotech consultant such as yourself.
Oh by the by Thal how is good old Mike doing these days? Too bad he sold off all of his holdings. Do you think either you or he could get in touch with the SEC and save all of us shareholders from this crazy scam? Here is the SEC address: http://www.sec.gov/
Just email them about your concerns with regard to CYGX Aldevron and GE Healthcare.
Give Mike S. my best wishes. It is not often a person gets over 3 million shares and dumps out before the train begins to roll. Only in America. (me laughing at you Thal)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.